Current Treatment Options in Psychiatry Template
Write in a clean editor, then format for Current Treatment Options in Psychiatry in one click — DocuGuru applies the official Springer Nature template with superscript references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
About the Current Treatment Options in Psychiatry format
Current Treatment Options in Psychiatry is a peer-reviewed journal published by Springer Nature, covering Posttraumatic Stress Disorder Research, Schizophrenia research and treatment, Bipolar Disorder and Treatment.
| Publisher | Springer Nature |
|---|---|
| Reference style | Superscript numbered (Nature) Superscript — small raised numerals in the text 1. Smith, A., Jones, B. & Lee, C. A representative article title. Current Treatment Options in Psychiatry 12, 45–58 (2023).
Formats any DOI in Current Treatment Options in Psychiatry style. No sign-up. |
| Publishes research in | Posttraumatic Stress Disorder Research Schizophrenia research and treatment Bipolar Disorder and Treatment Digital Mental Health Interventions Child and Adolescent Psychosocial and Emotional Development |
| ISSN | 2196-3061 |
| Citation impact (2-yr) | 4.83 |
| h-index | 40 |
| i10-index | 155 |
| Total citations | 6,315 |
| Article processing charge | $4,090 |
| Top institutions publishing here | Harvard University |
| Journal website | www.springer.com |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Papers published in Current Treatment Options in Psychiatry per year
Citation impact of Current Treatment Options in Psychiatry by publication year
Citations each year’s papers have accumulated so far — the most recent years are still building up.
Most-cited papers in Current Treatment Options in Psychiatry
Purpose of the review: Digital mental health interventions (DMHIs) are an effective and accessible means of addressing the unprecedented levels of mental illness worldwide. Currently, however, patient engagement with DMHIs in real-world settings is often insufficient to see clinical benefit. In order to realize the potential of DMHIs, there is a need to better understand…
Interest in the negative symptoms of schizophrenia has increased rapidly over the last several decades, paralleling a growing interest in functional, in addition to clinical, recovery, and evidence underscoring the importance negative symptoms play in the former. Efforts continue to better define and measure negative symptoms, distinguish their impact from that of other symptom domains,…